110 related articles for article (PubMed ID: 19723128)
1. Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study.
Lau D; Leung L; Ferdinands M; Allen PJ; Fullinfaw RO; Davies GE; Kong DC
Clin Exp Ophthalmol; 2009 Mar; 37(2):197-200. PubMed ID: 19723128
[TBL] [Abstract][Full Text] [Related]
2. Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study.
Lau D; Fedinands M; Leung L; Fullinfaw R; Kong D; Davies G; Daniell M
Arch Ophthalmol; 2008 Mar; 126(3):343-6. PubMed ID: 18332313
[TBL] [Abstract][Full Text] [Related]
3. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA
Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293
[TBL] [Abstract][Full Text] [Related]
4. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
Vemulakonda GA; Hariprasad SM; Mieler WF; Prince RA; Shah GK; Van Gelder RN
Arch Ophthalmol; 2008 Jan; 126(1):18-22. PubMed ID: 18195213
[TBL] [Abstract][Full Text] [Related]
5. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
[TBL] [Abstract][Full Text] [Related]
6. Clearance of intravitreal voriconazole.
Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
[TBL] [Abstract][Full Text] [Related]
7. Aqueous humor concentration of voriconazole after topical administration in rabbits.
Vorwerk CK; Streit F; Binder L; Tuchen S; Knop C; Behrens-Baumann W
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1179-83. PubMed ID: 18491124
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops.
Cekiç O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Can J Ophthalmol; 1998 Dec; 33(7):373-6. PubMed ID: 9885752
[TBL] [Abstract][Full Text] [Related]
9. Penetration of a topically administered anti-tumor necrosis factor alpha antibody fragment into the anterior chamber of the human eye.
Thiel MA; Wild A; Schmid MK; Job O; Bochmann F; Loukopoulos V; Alcantara W; Schmidt A; Lichtlen P; Escher D
Ophthalmology; 2013 Jul; 120(7):1403-8. PubMed ID: 23490328
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intracameral voriconazole injection.
Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee HN; Wei LC
Antimicrob Agents Chemother; 2009 May; 53(5):2156-7. PubMed ID: 19258273
[TBL] [Abstract][Full Text] [Related]
12. Prospective open-label study of the administration of two-percent voriconazole eye drops.
Al-Badriyeh D; Leung L; Roydhouse T; Fullinfaw R; Daniell M; Davies GE; Stewart K; Kong DC
Antimicrob Agents Chemother; 2009 Jul; 53(7):3153-5. PubMed ID: 19433565
[TBL] [Abstract][Full Text] [Related]
13. Corneal Pharmacokinetics of Voriconazole and Posaconazole following Intrastromal Injection and Posaconazole Eye Drops Instillation in Rats.
Gueudry J; Le Goff L; Lamoureux F; Pereira T; Levefre S; Razakandrainibe R; Costa D; Ballet JJ; Muraine M; Favennec L
Curr Eye Res; 2020 Nov; 45(11):1369-1372. PubMed ID: 32228098
[No Abstract] [Full Text] [Related]
14. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
[TBL] [Abstract][Full Text] [Related]
15. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration.
Cekiç O; Batman C; Yasar U; Başci NE; Bozkurt A; Kayaalp SO
Eye (Lond); 1999 Aug; 13 ( Pt 4)():555-8. PubMed ID: 10692930
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of voriconazole after single dose intravenous and oral administration to alpacas.
Chan HM; Duran SH; Walz PH; Ravis WR
J Vet Pharmacol Ther; 2009 Jun; 32(3):235-40. PubMed ID: 19646087
[TBL] [Abstract][Full Text] [Related]
17. Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops.
Neoh CF; Leung L; Chan E; Al-Badriyeh D; Fullinfaw RO; Jhanji V; Vajpayee RB; Davies GE; Stewart K; Kong DC
Antimicrob Agents Chemother; 2016 Nov; 60(11):6896-6898. PubMed ID: 27550348
[TBL] [Abstract][Full Text] [Related]
18. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Pascual A; Nieth V; Calandra T; Bille J; Bolay S; Decosterd LA; Buclin T; Majcherczyk PA; Sanglard D; Marchetti O
Antimicrob Agents Chemother; 2007 Jan; 51(1):137-43. PubMed ID: 17088483
[TBL] [Abstract][Full Text] [Related]
19. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery.
Güngör SG; Akova YA; Bozkurt A; Yasar Ü; Babaoğlu MÖ; Çetinkaya A; Çolak M
Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410
[TBL] [Abstract][Full Text] [Related]
20. Distribution of voriconazole in seven body fluids of adult horses after repeated oral dosing.
Passler NH; Chan HM; Stewart AJ; Duran SH; Welles EG; Lin HC; Ravis WR
J Vet Pharmacol Ther; 2010 Feb; 33(1):35-41. PubMed ID: 20444023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
